BofA cuts Westlake Chemical stock price target on weak earnings By Investing.com

Westlake Chemical reported first-quarter EBITDA of $235 million, well below the $335 million consensus, and EPS of -$0.77 versus -$0.17 expected, prompting a 6% share drop to $101.54. BofA Securities cut its price target to $104 from $119 while keeping a Neutral rating, citing lower confidence after the miss and a weaker starting point for profits. The firm still sees benefit from a price recovery in the market and expects fiscal 2026 EPS of $4.13, implying a return to profitability.

Analysis

WLK looks less like a one-off earnings miss and more like a margin-reset problem in a commodity chain where the first derivative matters more than the absolute level. When contract pricing lags spot, downside prints can stay ugly for one or two quarters even if the underlying market has already turned, which is why the near-term setup is still negative despite the potential for a later cyclical recovery. The key second-order issue is that distributors and downstream buyers now have a stronger incentive to delay restocking until they see evidence the reset has fully washed through, extending the earnings air pocket.

The bigger takeaway for the chemicals group is dispersion: names with cleaner balance sheets, less contract exposure, or more specialty mix should outperform while investors punish anything that looks levered to PVC/ethylene volumes and weak pricing pass-through. If WLK’s issue is indeed a calendar-roll mismatch, the sector may be approaching a point where the bad news is incremental rather than absolute, but that is usually a trade for 2-3 quarters out, not days. In the meantime, every weak print raises the hurdle for management credibility and multiple expansion.

Consensus may be underestimating how much of the next rally in WLK depends on a broad price recovery rather than company-specific execution. That makes the stock vulnerable to another leg down if the commodity rebound stalls or if peers confirm the same margin pressure. The contrarian angle is that a deeply depressed base can produce sharp upside on even modest sequential improvement, but only after the market sees one clean quarter of inventory normalization and margin stabilization.

Key Decisions for Investors

• Short WLK on any post-earnings bounce; use a 4-8 week horizon. Risk/reward is attractive if the market keeps fading the idea of an imminent rebound, with a likely retest of recent lows before any stabilization.
• Prefer a relative-value pair: long higher-quality chemical specialty exposure vs short WLK over the next 1-3 months. The thesis is that investors will pay up for cleaner earnings visibility while punishing commodity beta.
• If looking for an option expression, buy WLK put spreads 1-2 quarters out rather than outright puts. This captures a delayed downside continuation while limiting carry if the sector sees a sharp mean reversion.
• Avoid adding until there is evidence of sequential EBITDA recovery and inventory normalization. The first credible inflection quarter is the better entry than trying to catch the bottom now.
• Watch for read-through to other PVC and commodity chemical names; if peers guide down next, use that as confirmation to increase the short rather than cover it.